Does contractility modulation have a role in the treatment of heart failure?

Current Heart Failure Reports

Volumn 8, Issue 4, 2011, Pages 260-265

  Burkhoff, Daniel ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Anaerobic threshold; Cardiac contractility modulation; Cardiac resynchronization therapy; Ejection fraction; Heart failure; Myocardial infarction; Peak VO2; Prevention; Quality of life; Refractory period

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); EXERCISE TOLERANCE; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REFRACTORY PERIOD; HUMAN; PROTEIN PHOSPHORYLATION; QUALITY OF LIFE;

CARDIAC RESYNCHRONIZATION THERAPY; ELECTROCARDIOGRAPHY; HEART FAILURE; HUMANS; MYOCARDIAL CONTRACTION;

EID: 81355161559     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-011-0067-3     Document Type: Article

References (36)

1. WT Abraham WG Fisher AL Smith, et al. 2002 Cardiac resynchronization in chronic heart failure N Engl J Med 346 1845 53 12063368 10.1056/NEJMoa013168 (Pubitemid 34603028)
2. MR Bristow LA Saxon J Boehmer, et al. 2004 Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2140 50 15152059 10.1056/NEJMoa032423 1:CAS:528:DC%2BD2cXktF2isrc%3D (Pubitemid 38637994)
3. AJ Moss WJ Hall DS Cannom, et al. 2009 Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 1329 38 19723701 10.1056/NEJMoa0906431
4. Beshai JF, Grimm RA, Nagueh SF, et al.: Cardiac-Resynchronization Therapy in Heart Failure with Narrow QRS Complexes. N Engl J Med 2007.
5. HJ Shenkman V Pampati AK Khandelwal, et al. 2002 Congestive heart failure and QRS duration: establishing prognosis study Chest 122 528 34 12171827 10.1378/chest.122.2.528 (Pubitemid 35002131)
6. C Pappone S Rosanio D Burkhoff, et al. 2002 Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 90 1307 13 12480039 10.1016/S0002-9149(02)02868-0 (Pubitemid 35449475)
7. C Butter J Meyhofer M Seifert, et al. 2007 First use of cardiac contractility modulation (CCM) in a patient failing CRT therapy: clinical and technical aspects of combined therapies Eur J Heart Fail 9 955 8 17597000 10.1016/j.ejheart.2007.05.012 (Pubitemid 47332313)
8. H Nagele S Behrens C Eisermann 2008 Cardiac contractility modulation in non-responders to cardiac resynchronization therapy Europace 10 1375 80 18776196 10.1093/europace/eun257 1:STN:280:DC%2BD1cjkvFCitA%3D%3D
9. EH Wood RL Heppner S Weidmann 1969 Inotropic effects of electric currents: 1. Positive and negative effects of constant electric currents or current pulses applied during cardiac action potential Circ Res 24 409 45 5766519 1:STN:280:DyaF1M7hsl2hug%3D%3D
10. EH Wood RL Heppner S Weidmann 1969 Inotropic effects of electric currents: 2. Hypotheses: calcium movements, excitation-contraction coupling and inotropic effects Circ Res 24 409 45 5766519 1:STN:280:DyaF1M7hsl2hug%3D%3D
11. H Antoni R Jacob R Kaufmann 1969 Mechanical response of the frog and mammalian myocardium to changes in the action potential duration by constant current pulses Pflugers Arch 306 33 57 4975967 10.1007/BF00586610 1:STN:280:DyaF1M7ls1Chtw%3D%3D
12. Kaufmann RL, Antoni H, Hennekes R, et al.: Mechanical response of the mammalian myocardium to modifications of the action potential. Cardiovasc Res 1971; 1:Suppl-70.
13. M Blank R Goodman 2004 Initial interactions in electromagnetic field-induced biosynthesis J Cell Physiol 199 359 63 15095282 10.1002/jcp.20004 1:CAS:528:DC%2BD2cXjvVOqsb8%3D (Pubitemid 38580431)
14. D Burkhoff I Shemer B Felzen, et al. 2001 Electric currents applied during the refractory period can modulate cardiac contractility in vitro and in vivo Heart Fail Revs 6 27 34 10.1023/A:1009851107189 1:STN:280: DC%2BD3MzptFygug%3D%3D (Pubitemid 32328165)
15. HN Sabbah W Haddad Y Mika, et al. 2001 Cardiac contractilty modulation with the impulse dynamics signal: Studies in dogs with chronic heart failure Heart Failure Reviews 6 45 53 11248767 10.1023/A:1009855208097 1:STN:280:DC%2BD3MzptFynsg%3D%3D (Pubitemid 32328167)
16. S Mohri KL He M Dickstein, et al. 2002 Cardiac contractility modulation by electric currents applied during the refractory period Am J Physiol Heart Circ Physiol 282 H1642 H1647 11959626 1:CAS:528:DC%2BD38XjslWmsbo%3D
17. H Morita G Suzuki W Haddad, et al. 2003 Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure J Card Fail 9 69 75 12612875 10.1054/jcaf.2003.8 (Pubitemid 36356704)
18. T Lawo M Borggrefe C Butter, et al. 2005 Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration J Am Coll Cardiol 46 2229 36 16360051 10.1016/j.jacc.2005.05.093 (Pubitemid 41785490)
19. •• Imai M, Rastogi S, Gupta RC, et al.: Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. J Am Coll Cardiol 2007; 49:2120-8. This paper describes the results of a detailed study of the biochemical and molecular effects of CCM in an established model of heart failure. The results demonstrate the relatively rapid primary effects on phosphorylation, gene expression, and protein content in the vicinity of the signal delivery and the presumed secondary effects on remote areas that are observed within a 3-month timeframe. (Pubitemid 46771049)
20. •• Yu CM, Chan JY, Zhang Q, et al.: Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling. JACC Cardiovasc Imaging 2009; 2:1341-9. This study shows that CCM treatment for 3 months induces reverse ventricular remodeling, manifest as reduction in end-systolic and end-diastolic size and improved ejection fraction.
21. •• Butter C, Rastogi S, Minden HH, et al.: Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol 2008; 51:1784-9. This myocardial biopsy study confirms that 3 months of CCM therapy in patients with heart failure induces reverse molecular remodeling and drives the genotype from the abnormal fetal program characteristic of heart failure to a more normal adult profile. Interestingly, the magnitude of changes in gene expression correlated with clinical effectiveness, as quantified by exercise tolerance and quality-of-life scores. (Pubitemid 351608495)
22. C Butter E Wellnhofer M Schlegl, et al. 2007 Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption J Card Fail 13 137 42 17395055 10.1016/j.cardfail.2006.11.004 (Pubitemid 46467396)
23. HN Sabbah RC Gupta S Rastogi, et al. 2006 Treating heart failure with cardiac contractility modulation electrical signals Curr Heart Fail Rep 3 21 4 16684493 10.1007/s11897-006-0027-5 (Pubitemid 44623913)
24. C Pappone G Vicedomini A Salvati, et al. 2001 Electrical modulation of cardiac contractility: clinical aspects in congestive heart failure Heart Fail Rev 6 55 60 11248768 10.1023/A:1009807309006 1:STN:280:DC%2BD3MzptFynsA%3D%3D (Pubitemid 32328168)
25. C Pappone G Augello S Rosanio, et al. 2004 First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study J Cardiovasc Electrophysiol 15 418 27 15089990 10.1046/j.1540-8167.2004.03580.x (Pubitemid 38510099)
26. G Stix M Borggrefe C Wolpert, et al. 2004 Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure Eur Heart J 25 650 5 15084369 10.1016/j.ehj.2004.02.027 (Pubitemid 38579493)
27. •• Borggrefe MM, Lawo T, Butter C, et al.: Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J 2008; 29:1019-28. This was the first prospective, randomized, double-blind study showing that CCM improves exercise tolerance and quality of life in patients with heart failure and EF of 35% or less. (Pubitemid 351844673)
28. 2 was about 0.7 mL/kg/min greater in the treatment group compared to the control group. The primary safety end point of the study was met. The analysis revealed a subgroup of patients with particularly good response that now is being analyzed in a new study being conducted in the United States.
29. • Abraham WT, Burkhoff D, Nademanee K, et al.: A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. Am Heart J 2008; 156:641-8. This article provides a detailed description of the methodology and rationale for the United States study design. Several anticipated difficulties of the study were discussed in detail.
30. • Myers J, Goldsmith RL, Keteyian SJ, et al.: The ventilatory anaerobic threshold in heart failure: a multicenter evaluation of reliability. J Card Fail 2010; 16:76-83. This article provides a detailed analysis of the United States study data highlighting the difficulties in using the anaerobic threshold as a primary study end point.
31. SB Neelagaru JE Sanchez SK Lau, et al. 2006 Nonexcitatory, cardiac contractility modulation electrical impulses: Feasibility study for advanced heart failure in patients with normal QRS duration Heart Rhythm 3 1140 7 17018340 10.1016/j.hrthm.2006.06.031 (Pubitemid 44464160)
32. T De Marco E Wolfel AM Feldman, et al. 2008 Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study J Card Fail 14 9 18 18226768 10.1016/j.cardfail.2007.08.003
33. S Thackray A Coletta P Jones, et al. 2001 Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF Eur J Heart Fail 3 491 4 11511436 10.1016/S1388-9842(01) 00175-1 1:STN:280:DC%2BD3Mvms1ClsQ%3D%3D (Pubitemid 32780527)
34. JB Young WT Abraham AL Smith, et al. 2003 Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial JAMA 289 2685 94 12771115 10.1001/jama.289.20.2685 (Pubitemid 37430139)
35. C Linde C Leclercq S Rex, et al. 2002 Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study J Am Coll Cardiol 40 111 8 12103264 10.1016/S0735-1097(02)01932-0 (Pubitemid 34701385)
36. JG Cleland MJ Calvert Y Verboven N Freemantle 2009 Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study Am Heart J 157 457 66 19249415 10.1016/j.ahj.2008.11.006